Surface Plasmon Resonance Market Report 2025

This surface plasmon resonance market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The surface plasmon resonance market size has grown rapidly in recent years. It will grow from $1.19 billion in 2024 to $1.33 billion in 2025 at a compound annual growth rate (CAGR) of 12%. The growth in the historic period can be attributed to increasing advances in biotechnology, increasing demand for drug discovery and development, rising applications in clinical diagnostics, growing emphasis on protein interaction studies, and increasing academic research funding.

The surface plasmon resonance market size is expected to see rapid growth in the next few years. It will grow to $2.07 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to rising demand for personalized medicine, increasing applications in food safety testing, growing focus on biomarker discovery, expanding use in environmental monitoring, and increasing adoption in the agricultural biotechnology sector. Major trends in the forecast period include demand for label-free detection technologies, adoption of personalized medicine, advancements in nanotechnology, development of portable and miniaturized SPR systems, and integration with artificial intelligence for data analysis.

The growing adoption of personalized medicine is expected to drive the surface plasmon resonance market forward. Personalized medicine tailors healthcare based on an individual's genetic, environmental, and lifestyle factors to create customized treatment and prevention strategies. This approach is increasingly popular due to advancements in genomics, the rise of targeted therapies, and the need for more precise and effective treatments. Surface plasmon resonance supports personalized medicine by enabling real-time analysis of biomolecular interactions, identifying specific biomarkers, and optimizing drug therapies for individual patients. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, up from 6 in 2022. These approvals included seven cancer drugs and three for other diseases and conditions. Thus, the growing adoption of personalized medicine is driving the expansion of the surface plasmon resonance market.

Major companies in the surface plasmon resonance market are advancing biomolecular analysis technologies, such as injection technology, to streamline the process and eliminate the need for multiple dilution series. This technology simplifies biomolecular interaction analysis by integrating sample dilution and injection into a single step, speeding up data acquisition in surface plasmon resonance (SPR) with rapid, single-injection kinetics and affinity measurements. For example, in April 2022, Sartorius AG, a Germany-based pharmaceutical and laboratory equipment company, introduced the Octet SF3, an advanced surface plasmon resonance instrument designed for high-throughput, label-free biomolecular interaction analysis. This next-generation device is suited for both frequent and occasional users due to its robust, low-maintenance design. Its innovative OneStep and NeXtStep Gradient Injection technologies facilitate faster, high-quality kinetics and affinity data collection, significantly improving upon traditional methods. The Octet SF3 is tailored to meet the increasing global demand for antibody fragment characterization, vaccine research, and biologics discovery.

In November 2022, Nicoya, a Canada-based company specializing in SPR technologies, formed a partnership with INOVIQ Ltd. This collaboration is focused on developing a cancer risk assessment test using surface plasmon resonance (SPR) technology. The test aims to detect the pan-cancer biomarker Neu5Gc in blood samples and will be conducted on Nicoya's Alto platform. INOVIQ Ltd., an Australia-based biotechnology firm, specializes in diagnostic tests and cancer treatments using surface plasmon resonance platforms.

Major companies operating in the surface plasmon resonance market are GE HealthCare Technologies Inc., Sartorius AG, Cytiva, Bio-Rad Laboratories Inc., Bruker Corporation, HORIBA Ltd., Quanterix Corporation, Jubilant Biosys Limited, Quantum Design Inc., Reichert Inc., NanoSPR Devices, Creative BioMart Inc., Biocompare, Carterra Inc., NICOYA AB, Biosensing Instrument Inc., Plexera LLC, Insplorion AB, BioNavis Ltd., Affinité Instruments, IBIS Technologies B.V., Bioptix Inc.

North America was the largest region in the surface plasmon resonance market in 2024. The regions covered in the surface plasmon resonance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surface plasmon resonance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Surface plasmon resonance (SPR) is an optical technique used to measure molecular interactions by detecting changes in the refractive index on a sensor surface. This method allows for real-time, label-free analysis of various biomolecular interactions, such as those between proteins, DNA, and antibodies.

The main product types in surface plasmon resonance include imaging systems, sensor systems, and reagents. An imaging system is designed to visualize and analyze biomolecular interactions in real time. Key technologies in SPR imaging include prism-based SPR and grating-based SPR, among others. These systems are applied in various fields such as drug discovery, drug formulation, controlled drug release, drug-cell interactions, material science, and biosensors. They serve different end-users, including academic and research institutions, the food and beverage industry, biopharmaceutical companies, contract research organizations (CROs), and others.

The surface plasmon resonance market research report is one of a series of new reports that provides surface plasmon resonance market statistics, including surface plasmon resonance industry global market size, regional shares, competitors with a surface plasmon resonance market share, detailed surface plasmon resonance market segments, market trends and opportunities, and any further data you may need to thrive in the surface plasmon resonance industry. This surface plasmon resonance market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The surface plasmon resonance market consists of revenues earned by entities by providing services such as biosensor development services, assay development services, contract research services, data analysis services, and instrument maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The surface plasmon resonance market also includes sales of benchtop and portable SPR systems, metallic sensor chips, functionalized sensor chips, buffers, and solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.